The Brink's Company (BCO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jul, 2026Executive summary
Achieved 6% year-over-year revenue growth in Q3 2025, with AMS/DRS organic growth accelerating to 19% and now comprising 27–28% of total revenue.
Delivered record Q3 operating profit and EBITDA margins, with all performance metrics above the midpoint of guidance.
Free cash flow increased 30% year-over-year to $175 million in Q3, up 78% year-to-date, driven by improved profitability and working capital.
Reduced leverage below 3x and share count by 5–6% year-to-date, with $153.6–$154 million in share repurchases.
Strategic focus on organic growth, margin expansion, and maximizing shareholder value through capital returns and operational efficiency.
Financial highlights
Q3 2025 revenue: $1,335M, up 6% year-over-year, with 5% organic growth and 1% FX tailwind.
Adjusted EBITDA rose 17% to $253M, with margin expanding to 19.0% (+180bps YoY).
Operating profit up 24–37% year-over-year; GAAP operating profit $152M, non-GAAP $188M.
EPS increased 28–32% to $2.08 (non-GAAP) and $0.86 (GAAP); share count reduced by 5–6%.
Free cash flow conversion improved to 50% of Adjusted EBITDA on a trailing 12-month basis.
Outlook and guidance
Affirmed full-year framework, passing Q3 outperformance through to year-end.
Q4 2025 revenue guidance: $1,330M–$1,380M; adjusted EBITDA: $267M–$287M; non-GAAP EPS: $2.28–$2.68.
Full-year 2025 organic growth expected in mid-single digits, AMS/DRS in mid-to-high teens, with 30–50bps EBITDA margin expansion and 40–45% free cash flow conversion.
Free cash flow conversion targeted at 40–45%, with at least 50% of FCF returned to shareholders.
Guidance incorporates currency volatility and assumes continuation of current economic trends.
Latest events from The Brink's Company
- Record Q2 revenue, 14% organic growth, and margin expansion drive strong 2024 outlook.BCO
Q2 20248 Jul 2026 - Shareholders approved a key share issuance for a merger, with quorum and results confirmed.BCO
AGM 202630 Jun 2026 - Q1 2026 delivered 10% revenue growth, margin gains, and record free cash flow, with NCR Atleos on track.BCO
Q1 20266 May 2026 - Annual meeting covers director elections, pay, auditor, equity plan, and ESG-linked proposals.BCO
Proxy filing20 Mar 2026 - $6.6B merger forms a global fintech leader with $200M synergies and expanded reach.BCO
M&A announcement27 Feb 2026 - $6.6B deal forms a $10B revenue fintech leader with $200M synergies and record cash flow.BCO
Q4 202526 Feb 2026 - AMS/DRS growth outpaced expectations, but FX and security losses pressured Q3 profits.BCO
Q3 202416 Jan 2026 - AMS/DRS drove 12% organic growth, margin expansion, and strong cash flow in 2024.BCO
Q4 202417 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, with focus on governance and ESG.BCO
Proxy Filing1 Dec 2025